IKTOS
Incorporated in October 2016, Iktos is a start-up company specializing in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existing data, the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos techno... logy enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as a professional services and as a SaaS software platform. Iktos offers Makya™, ligand and structure-based de novo drug design platform for multi-parametric optimisation (MPO) of lead compounds in line with Target Candidate Profile (TCP). Iktos is also developing Spaya™, a synthesis planning software based upon Iktos’s proprietary AI technology for retrosynthesis.
IKTOS
Industry:
Artificial Intelligence Biotechnology Chemical Health Care Machine Learning Pharmaceutical
Founded:
2016-10-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.iktos.ai
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Investors List
AGORANOV
AGORANOV investment in Non Equity Assistance - Iktos
Official Site Inspections
http://www.iktos.ai Semrush global rank: 5.55 M Semrush visits lastest month: 1.53 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Iktos"
About - Iktos
PhD in Artificial Intelligence. Several years experience in software development and R&D. Contributed to the emerging data science field by creating distributed computation platform for Big Data processing. Co-founder and CTO at Iktos, …See details»
Drug Discovery Collaborations - iktos.ai
Partner with Iktos to identify your next preclinical candidate in less than two years ... Subscribe to our newsletter to receive the latest updates on AI-driven drug discovery from Iktos. Subscribe. …See details»
Iktos - Crunchbase Company Profile & Funding
Iktos is a French scale-up company specializing in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos’ proprietary and innovative generative AI solution enables the design of …See details»
Iktos Company Profile 2024: Valuation, Funding & Investors
The company's platform specializes in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design, applied to chemical research, …See details»
How Iktos Wants To Revolutionize Drug Discovery With AI And …
Nov 15, 2024 In the race to accelerate drug discovery through artificial intelligence, French startup Iktos has emerged as a pioneer in Europe, developing an integrated platform that …See details»
Iktos - Products, Competitors, Financials, Employees, Headquarters ...
» About Iktos Iktos is a French scale-up company specializing in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos’ proprietary …See details»
Merck KGaA signs another AI deal - pharmaphorum
5 days ago Merck KGaA is doubling down on AI through a new collaboration agreement with tech firm Iktos, using its generative modelling technology to speed up the discovery and …See details»
Iktos Secures €15.5 Million in Funding to Accelerate AI …
Mar 13, 2023 French startup Iktos has secured €15.5 million in Series A funding for its AI-powered drug discovery platform. The round was co-led by M Ventures and Debiopharm Innovation Fund, with participation from Omnes Capital, and …See details»
Iktos and Nerviano Medical Sciences S.r.l Announce …
Jan 8, 2024 NERVIANO Italy and PARIS France, January 8, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, and Nerviano Medical Sciences S.r.l (NMS), a leading Italian clinical stage biotech …See details»
Iktos Company Profile - Office Locations, Competitors, Revenue
Iktos is a company developing an artificial intelligence technology for ligand-based drug design, focusing on MPO (multi-parametric optimization). Its proprietary algorithm is based on deep …See details»
Iktos Announces a Collaboration With Ono in Artificial Intelligence …
Mar 30, 2022 About Iktos Incorporated in October 2016, Iktos is a start-up company specializing in the development of artificial intelligence solutions applied to chemical research, more …See details»
SANOFI, AWS, IKTOS, ELAIA and MIND GROUP at AI for Health – …
AI for Health Summit - 2024 Edition. Key learnings from the panel discussion on on “The GenAI revolution for drug discovery” with Yann Gaston-Mathé, CEO & Founder of Iktos, Alex Merwin …See details»
Iktos Robotics
Iktos Robotics The Future of Drug Discovery. Imagine a future where the full Design-Make-Test-Analysis cycle is totally automated. ... Subscribe to our newsletter to receive the latest updates …See details»
Iktos - Overview, News & Similar companies | ZoomInfo.com
Who is Iktos. Incorporated in October 2016, Iktos is a French start-up company specialized in the development of artificial intelligence solutions applied to che mical research, more specifically …See details»
Iktos Company Profile: AI, Investments, Contact Information, News ...
Iktos is a French start-up company which develops a truly innovative and disruptive artificial intelligence technology for ligand and structure-based de novo drug design.Our innovative …See details»
Iktos - Pharmaceutical Technology
Iktos, is a developer of artificial intelligence for new drug design that developing a proprietary and innovative solution based on deep learning generative models. The company is headquartered …See details»
Iktos Company Information - Funding, Investors, and More
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»
Iktos, the start-up that puts AI at the service of pharmaceutical ...
May 31, 2022 Iktos, the start-up that puts AI at the service of pharmaceutical research 05.31.2022 Specializing in the development of artificial intelligence (AI) solutions applied to …See details»
Kayrros unveils methane monitoring AI tool - Axios
4 days ago Environmental intelligence firm Kayrros is rolling out a large language model (LLM) to allow the public to pinpoint methane-emitting facilities, the company first told Axios.. Why it …See details»
Artificial intelligence moves forward, cancer retreats - Iktos
Nov 15, 2024 A new generation of startups AI-boosted is designing exclusive molecules that could become tomorrow’s cancer treatments. This thematic was central during the last forum …See details»